5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Aarey Drugs & Pharmaceuticals Ltd.

•
aareydrugs.comBSE: 524412NSE: AAREYDRUGS
Market Cap₹ 306 Cr.
Current Price
High / Low₹ 101 / 50
Stock P/E73.4
Book Value₹ 53
Price to Book0.71
Dividend Yield0.00 %
ROCE6.4 %
ROE3.0 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Oil Gas & Consumable Fuels

Reduce

Sector economics are clouded by input volatility and uneven volume trends. WPI fuel inflation is very high at 20.05% (Jul/26), crude oil output is -5.3% YoY (2026-07), natural gas is -3.7% YoY (2026-07), and natural gas consumption is -3.0% YoY (2026-06), although refinery products grew 2.7% YoY (2026-07) and coal was 7.6% YoY (2026-07). Heavy FPI outflows of INR -15293 crore over 3 months to 2026-08-31 and negative oil-linked news flow reinforce the underweight.

Confidence
78%
View full sector analysis →

PROS

  • Institutional investors have been accumulating - FII+DII up 2.8pp
  • Company maintains a comfortable, low leverage position
  • Company converts assets efficiently - asset turnover of 1.6x

CONS

  • A large part of profit comes from other income (160.8% of PBT)
  • Company has a low return on equity of 3.4% over last 3 years
  • Company has a low return on capital employed of 6.2%
  • Promoter holding has decreased over last 2 years: -7.6pp
  • Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT 0.48x)
  • Operating cash flow has been negative in recent years

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

Oil Gas & Consumable FuelsTradingTrading
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.ADANIENT3057.1055.59413846.540.04-1461.54-249.6732923.9849.9213.3015.57
2.AEGISLOG1353.1037.9647493.810.64544.84210.702356.8637.0719.7630.28
3.CPPLUS3830.1594.9445310.840.04142.20332.511402.4289.5129.4814.52
4.PREMIERENE974.5526.5744239.840.10471.9253.322462.5935.2533.7229.03
5.REDINGTON393.6518.0930774.551.52453.4994.6534922.4734.5718.962.03
6.HONASA470.9561.7015354.110.6490.45118.87755.9527.0020.8714.58
7.LLOYDSENT69.7994.8810653.810.21109.98-55.77563.0370.1512.8418.07
8.SGMART751.2576.169468.390.00455.801310.7113085.701044.0810.434.49
9.MMTC61.9620.789294.000.00104.24135.520.68-50.0033.46-1423.53
10.ENTERO1819.3563.147918.370.0052.0572.171940.5038.2310.935.00
11.EBGNG683.0054.677786.990.0028.9356.21412.4632.0820.5811.97
12.AAREYDRUGS99.2373.36306.370.001.02-25.2644.63-56.346.382.97
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
515876210127105134108102849618945
505674212126101132112101829818546
Operating Profit123-1142-423-24-1
OPM %2.63%3.20%3.54%-0.68%0.93%3.54%1.64%-3.89%1.66%3.14%-1.57%2.29%-2.69%
11052018214-02
Interest1111121111122
Depreciation0000001001111
Profit before Tax1112121221111
Tax %0.00%21.78%30.14%-0.47%6.77%8.57%48.57%71.60%20.81%31.08%38.04%-21.88%-98.64%
Net Profit1112121011121
0.290.310.400.770.440.570.260.170.480.360.200.550.36

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
246396349355300348493419398474415
245386341347297344481411391471410
Operating Profit1108835118634
OPM %0.41%2.43%2.19%2.22%1.08%1.33%2.31%1.84%1.63%0.61%1.03%
333477335106
Interest24222223456
Depreciation11111122223
Profit before Tax288978106564
Tax %28.88%31.39%24.59%27.20%20.00%21.53%34.69%37.25%12.34%34.05%0.52%
Net Profit15676774544
EPS0.773.032.642.642.802.792.721.491.671.41—
Dividend Payout %0.00%0.00%0.00%3.57%0.00%0.00%0.00%0.00%0.00%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
8%
5 Years:
10%
3 Years:
-1%

COMPOUNDED PROFIT GROWTH

10 Years:
14%
5 Years:
-7%
3 Years:
-15%

STOCK PRICE CAGR

10 Years:
—
5 Years:
22%
3 Years:
26%
1 Year:
34%

RETURN ON EQUITY

10 Years:
6%
5 Years:
5%
3 Years:
3%
Last Year:
3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

No bonus data found

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Equity Capital17182323232325252828
2030556167738690102108
1510316181814383135
Trade Payables7275783778110110127129103
291188810111317
Total Liabilities125142170146194233245291303291
8121212121414141316
0000000012
251521171814293545
00000000184133
Cash & Bank2130110121
1131241391111641992162476892
Total Assets125142170146194233245291303291

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
63-1834741-310
Cash from Investing-3-5-1-1-1-3-30-2-6
Cash from Financing-2423-2-2-2216-4
1-12-300-011-0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
45.2845.4444.8044.8044.8044.8039.0637.7137.71
3.402.752.342.341.971.133.864.184.81
DIIs0.000.000.000.000.000.000.000.000.00
Government0.000.000.000.000.000.000.000.000.00
51.3351.8152.8652.8653.2354.0757.0958.1157.48

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-11
General Updates

2026-09-11 - Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about the AGM Intimation letter that has been sent to the Shareholders under Regulation 36(1)(b) of the SEBI Listing Regulations, 2015

2026-09-09
Copy of Newspaper Publication

2026-09-09 - Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

2026-09-08
Shareholders meeting

2026-09-08 - Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026

2026-09-08
Updates

2026-09-08 - Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding ''.Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of Book Closure/ E-Voting period for the 36th Annual General Meeting

2026-09-05
Outcome of Board Meeting

2026-09-05 - Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on September 05, 2026.

2026-08-20
Copy of Newspaper Publication

2026-08-20 - Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-14
Outcome of Board Meeting

2026-08-14 - Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the unaudited financial results for the period ended Jun 30, 2026.

2026-08-06
Outcome of Board Meeting

2026-08-06 - Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 06, 2026.

2026-07-08
Certificate under SEBI (Depositories and Participants) Regulations, 2018

2026-07-08 - Aarey Drugs & Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

News

Recent coverage and analyst commentary for AAREYDRUGS

Loading news…

🤖

AI Stock Analyst

Aarey Drugs & Pharmaceuticals Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login